Adjunctive thrombus aspiration versus conventional percutaneous coronary intervention in ST-elevation myocardial infarction

Wouter J. Kikkert, Bimmer E. Claessen, Nan Van Geloven, Jan Baan, Marije M. Vis, Karel T. Koch, Jan J. Piek, Jan G.P. Tijssen, Jose P.S. Henriques

Research output: Contribution to journalArticlepeer-review

14 Scopus citations


Objectives The objective of this analysis is to determine the effects on mortality of thrombus aspiration during primary percutaneous coronary intervention (PPCI) for ST-elevation myocardial infarction (STEMI) compared with conventional PCI. Background Adjunctive thrombus aspiration in STEMI improves markers of myocardial reperfusion but evidence for improved survival is limited to the TAPAS trial. Methods We used data of 3,750 consecutive STEMI patients treated with either conventional PCI or thrombus aspiration between August 1, 2001 and January 1, 2009. For each patient, a propensity score was calculated based on clinical and angiographic characteristics, predicting a patient's probability of having been treated with thrombus aspiration. This propensity score was used in several ways to account for differences between patients treated with and without thrombus aspiration. In our primary analysis, patients treated with thrombus aspiration were matched one-to-one with patients treated with conventional PCI on their propensity score (1,391 matched pairs). Kaplan Meier and Cox regression models were used to estimate the influence of treatment on one-year mortality. Results In total, 1,502 patients (40.1%) were treated with thrombus aspiration. In the propensity matched cohort, after one year 7.2% of patients treated with thrombus aspiration had died compared with 9.3% of patients in the control group. The hazard ratio for one-year mortality in patients treated with thrombus aspiration was 0.76 (95% CI: 0.59-0.99; P = 0.043). The hazard ratio remained materially unaltered and statistically significant in secondary analyses, varying between 0.61 and 0.77. Conclusion The routine use of thrombus aspiration was associated with reduced one-year mortality in this large real-world patient cohort. These data support the observed survival benefit in the TAPAS trial.

Original languageEnglish
Pages (from-to)922-929
Number of pages8
JournalCatheterization and Cardiovascular Interventions
Issue number6
StatePublished - May 2013
Externally publishedYes


  • ST-segment elevation myocardial infarction
  • thrombectomy
  • thrombus aspiration


Dive into the research topics of 'Adjunctive thrombus aspiration versus conventional percutaneous coronary intervention in ST-elevation myocardial infarction'. Together they form a unique fingerprint.

Cite this